Product Code: ETC6183395 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The isothermal nucleic acid amplification technology (INAAT) market in Australia is gaining momentum, driven by its application in molecular diagnostics and disease detection. INAAT offers several advantages over traditional PCR methods, including faster results, simplicity, and cost-effectiveness. It is increasingly used for detecting a variety of infectious diseases and genetic disorders, offering quick turnaround times and the ability to perform tests outside of laboratory settings. This technology`s development is supported by the country`s healthcare sector`s focus on improving diagnostic capabilities and response times, positioning it as a key growth area in molecular diagnostics.
Isothermal Nucleic Acid Amplification Technology (INAAT) is gaining traction in Australia due to its potential in providing rapid, reliable, and cost-effective molecular diagnostic solutions. Unlike traditional PCR methods, INAAT operates at a constant temperature, which simplifies testing processes and reduces the need for expensive thermal cycling equipment. This market is driven by advancements in biotechnology and a growing emphasis on point-of-care diagnostics, which are essential in rural and remote areas of Australia. The ability to quickly detect infectious diseases such as COVID-19, tuberculosis, and sexually transmitted infections using INAAT systems has made it a preferred choice among healthcare providers and researchers.
Australias isothermal nucleic acid amplification technology (INAAT) market faces barriers related to high research and development costs and the need for technical expertise in deployment. Competition from polymerase chain reaction (PCR) technologies and slow adoption in clinical diagnostics hinder wider market penetration.
This advanced diagnostic technology offers quick and sensitive DNA/RNA detection, ideal for point-of-care testing. In Australia, investment potential exists in developing portable diagnostic kits for infectious diseases and agricultural use. Partnerships with biotech firms and public health bodies can help scale innovations that address both medical and environmental diagnostics.
The use of isothermal nucleic acid amplification technology (INAAT) in diagnostic applications is regulated by the Therapeutic Goods Administration under in-vitro diagnostic (IVD) regulations. Products must demonstrate clinical validity and safety before approval. The Australian government supports innovation in rapid diagnostic technologies through grants and research funding.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Isothermal Nucleic Acid Amplification Technology Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Isothermal Nucleic Acid Amplification Technology Market - Industry Life Cycle |
3.4 Australia Isothermal Nucleic Acid Amplification Technology Market - Porter's Five Forces |
3.5 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Australia Isothermal Nucleic Acid Amplification Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Isothermal Nucleic Acid Amplification Technology Market Trends |
6 Australia Isothermal Nucleic Acid Amplification Technology Market, By Types |
6.1 Australia Isothermal Nucleic Acid Amplification Technology Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Australia Isothermal Nucleic Acid Amplification Technology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Helicase-Dependent Amplification (HDA), 2021- 2031F |
6.2.3 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Nicking Enzyme Amplification Reaction (NEAR), 2021- 2031F |
6.2.4 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Loop-Mediated Isothermal Amplification (LAMP), 2021- 2031F |
6.2.5 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Strand Displacement Amplification (SDA), 2021- 2031F |
6.2.6 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Nucleic Acid Sequence-Based Amplification (NASBA), 2021- 2031F |
6.2.7 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Transcription Mediated Amplification (TMA), 2021- 2031F |
6.2.8 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Isothermal Nucleic Acid Amplification Technology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Infectious Disease Diagnosis, 2021- 2031F |
6.3.3 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Blood Screening, 2021- 2031F |
6.3.4 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Isothermal Nucleic Acid Amplification Technology Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.4.5 Australia Isothermal Nucleic Acid Amplification Technology Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Isothermal Nucleic Acid Amplification Technology Market Import-Export Trade Statistics |
7.1 Australia Isothermal Nucleic Acid Amplification Technology Market Export to Major Countries |
7.2 Australia Isothermal Nucleic Acid Amplification Technology Market Imports from Major Countries |
8 Australia Isothermal Nucleic Acid Amplification Technology Market Key Performance Indicators |
9 Australia Isothermal Nucleic Acid Amplification Technology Market - Opportunity Assessment |
9.1 Australia Isothermal Nucleic Acid Amplification Technology Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Isothermal Nucleic Acid Amplification Technology Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Australia Isothermal Nucleic Acid Amplification Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Isothermal Nucleic Acid Amplification Technology Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Australia Isothermal Nucleic Acid Amplification Technology Market - Competitive Landscape |
10.1 Australia Isothermal Nucleic Acid Amplification Technology Market Revenue Share, By Companies, 2024 |
10.2 Australia Isothermal Nucleic Acid Amplification Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |